info@marketresearchfuture.com   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)
Certified Global Research Member
Esomar23 wcrc
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Oral Cancer Diagnostics Market Size

ID: MRFR//6614-CR | 121 Pages | Author: Rahul Gotadki| July 2019

Oral Cancer Diagnostics Market Growth Projections and Opportunities

Cancer is when cells in the body grow uncontrollably, causing damage to nearby tissues. Oral cancer specifically refers to painful lumps or growths in the mouth that affect the surrounding tissues. This type of cancer includes conditions like lip, tongue, cheek, hard and soft palate, floor of the mouth, pharynx, and sinus cancers. While oral cancer can be treated, it can be life-threatening if not detected early and treated properly.

Diagnosing oral cancer is crucial because the treatment depends on the stage of cancer. The earlier the diagnosis, the easier it is to manage the cancerous growth. Various diagnostic tests, such as computed tomography (CT), magnetic resonance imaging (MRI), X-ray, and ultrasonography, are commonly used for the diagnosis of oral cancer.

The market for oral cancer diagnostics is growing due to factors like an increase in the population suffering from oral cancer, effective diagnostic tools, ongoing research and development, and a rise in risk factors leading to oral cancers. However, challenges include a shortage of trained professionals and healthcare organizations facing difficulties in purchasing expensive imaging systems, which may limit market growth.

The global oral cancer diagnostics market, valued at USD 4,909.60 million in 2018, is estimated to reach USD 7,367.90 million by 2024. In 2018, the Americas held the largest market share at 42.40%, with a value of USD 2,081.67 million, followed by Europe with USD 1,382.05 million.

In terms of indication, the oral squamous cell carcinoma segment held the largest market share of 89.02% in 2018, with a value of USD 4,370.55 million. This segment is projected to grow at a CAGR of 21.13% during the forecast period.

Regarding diagnosis type, the computed tomography (CT) segment had the largest market share of 30.07% in 2018, with a value of USD 1,476.13 million. It is expected to register a CAGR of 7.16% during the forecast period.

On the basis of end user, the hospitals and clinics segment dominated the market, accounting for a share of 45.81% in 2018, with a value of USD 2,249.08 million. This segment is anticipated to register a CAGR of 7.56% during the forecast period.

Covered Aspects:
Report Attribute/Metric Details
Growth Rate   4.8%  Base Year  2021  Forecast Period  2023-2032  Historical Data  2020  Forecast Units  Value (USD Million  Report Coverage  Revenue Forecast, Competitive Landscape, Growth Factors, and Trends  Segments Covered  Indication, Diagnosis Type, End User  Geographies Covered  North America, Europe, Asia-Pacific, and Rest of the World (RoW)  Key Vendors  Thermo Fisher Scientific Inc. (U.S.), Hoffmann-La Roche Ltd (Switzerland), Vigilant Biosciences Inc. (U.S.), Koninklijke Philips NV (Netherlands), Hitachi Ltd (Japan), Philips NV (Netherlands), QIAGEN (Germany), E. Healthcare (U.S.), Recent Developments, Koninklijke Philips NV (Netherlands), PeriRx LLC (U.S.)  Key Market Opportunities  New product launches and R&D Amongst major key Players  Key Market Drivers·  Increasing number of cases in the sector of oral cancer·  Growing pervasiveness for oral cancer·  Increased technological advancements for better facilities·  Diagnostic tools 
Leading companies partner with us for data-driven Insights
clients
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.